Journal
CELL CYCLE
Volume 9, Issue 2, Pages 371-376Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.9.2.10467
Keywords
retinoblastoma; pRB; E2F4; erythroid differentiation; cell cycle
Categories
Funding
- NIH [GM53204, CA121921]
- Leukemia & Lymphoma Society
- Pearl Staller fund
Ask authors/readers for more resources
The retinoblastoma tumor suppressor protein pRB functions, at least in part, by directly binding to and modulating the activity of the E2F transcription factors. Previous studies have shown that both E2F4 and pRB play important roles in fetal erythropoiesis. Given that these two proteins interact directly we investigated the overlap of E2F4 and pRB function in this process by analyzing E2f4(-/-), conditional Rb knockout (Rb-1lox/1lox), and compound E2f4(-/-); Rb-1lox/1lox embryos. At E15.5 E2f4(-/-) and Rb-1lox/1lox fetal erythroid cells display distinct abnormalities in their differentiation profiles. When cultured in vitro, both E2f4(-/-) and Rb-1lox/1lox erythroid cells show defects in cell cycle progression. Surprisingly, analysis of cell cycle profiling suggests that E2F4 and pRB control cell cycle exit through different mechanisms. Moreover, only pRB, but not E2F4, promotes cell survival in erythroid cells. We observed an additive rather than a synergistic impact upon the erythroid defects in the compound E2f4(-/-); Rb-1lox/1lox embryos. We further found that fetal liver macrophage development is largely normal regardless of genotype. Taken together, our results show that E2F4 and pRB play independent cell-intrinsic roles in fetal erythropoiesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available